Louisbourg Investments Inc. Has $11.27 Million Stock Position in Brookfield Co. (NYSE:BN)

Louisbourg Investments Inc. raised its holdings in shares of Brookfield Co. (NYSE:BN) by 18.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 196,124 shares of the company’s stock after purchasing an additional 30,287 shares during the quarter. Brookfield accounts for approximately 2.7% of Louisbourg Investments Inc.’s investment portfolio, making the stock its 5th largest holding. Louisbourg Investments Inc.’s holdings in Brookfield were worth $11,267,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. First Personal Financial Services purchased a new position in shares of Brookfield during the third quarter valued at $42,000. FSA Wealth Management LLC purchased a new position in shares of Brookfield during the third quarter valued at $42,000. Prestige Wealth Management Group LLC increased its stake in shares of Brookfield by 137.0% during the third quarter. Prestige Wealth Management Group LLC now owns 865 shares of the company’s stock valued at $46,000 after buying an additional 500 shares during the period. Continuum Advisory LLC purchased a new position in shares of Brookfield during the third quarter valued at $55,000. Finally, Pinnacle Bancorp Inc. increased its stake in shares of Brookfield by 29.5% during the fourth quarter. Pinnacle Bancorp Inc. now owns 969 shares of the company’s stock valued at $56,000 after buying an additional 221 shares during the period. 61.60% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on BN. TD Securities raised their price target on Brookfield from $74.00 to $75.00 and gave the company a “buy” rating in a research note on Tuesday. BMO Capital Markets restated an “outperform” rating and set a $62.00 price target (up previously from $50.00) on shares of Brookfield in a research note on Friday, November 15th. CIBC lifted their target price on Brookfield from $68.00 to $70.00 and gave the company an “outperformer” rating in a research note on Thursday, January 23rd. Morgan Stanley started coverage on Brookfield in a research note on Thursday, January 23rd. They issued an “overweight” rating and a $80.00 target price on the stock. Finally, Scotiabank lifted their target price on Brookfield from $69.00 to $71.00 and gave the company a “sector outperform” rating in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $64.00.

Brookfield Price Performance

Shares of BN stock opened at $58.67 on Wednesday. Brookfield Co. has a fifty-two week low of $38.18 and a fifty-two week high of $62.78. The firm has a market capitalization of $96.57 billion, a price-to-earnings ratio of 124.84 and a beta of 1.57. The company has a debt-to-equity ratio of 1.40, a quick ratio of 1.03 and a current ratio of 1.17. The stock’s 50-day simple moving average is $58.46 and its 200-day simple moving average is $54.36.

Brookfield Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th were paid a dividend of $0.08 per share. The ex-dividend date was Monday, December 16th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.55%. Brookfield’s payout ratio is 68.09%.

About Brookfield

Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. It manages a range of public and private investment products and services for institutional and retail clients.